WILLIAM PEACOCK to Creatine Kinase, MB Form
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Creatine Kinase, MB Form.
Connection Strength
0.932
-
Elevated serum cardiac markers predict coronary artery disease in patients with a history of heart failure who present with chest pain: insights from the i*trACS registry. Congest Heart Fail. 2007 May-Jun; 13(3):142-8.
Score: 0.282
-
Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction. J Am Heart Assoc. 2017 Sep 22; 6(9).
Score: 0.145
-
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet. 2011 Mar 26; 377(9771):1077-84.
Score: 0.092
-
Outcomes associated with small changes in normal-range cardiac markers. Am J Emerg Med. 2011 Feb; 29(2):162-7.
Score: 0.086
-
Risk stratification for suspected acute coronary syndromes and heart failure in the emergency department. Acute Card Care. 2009; 11(3):138-45.
Score: 0.079
-
Discordant cardiac biomarkers: frequency and outcomes in emergency department patients with chest pain. Ann Emerg Med. 2006 Dec; 48(6):660-5.
Score: 0.067
-
Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol. 2006 Jan 17; 47(2):312-8.
Score: 0.065
-
Retrospective review: the incidence of non-ST segment elevation MI in emergency department patients presenting with decompensated heart failure. Congest Heart Fail. 2003 Nov-Dec; 9(6):303-8.
Score: 0.055
-
Normal CK, elevated MB predicts complications in acute coronary syndromes. J Emerg Med. 2001 May; 20(4):385-90.
Score: 0.047
-
A randomized, placebo-controlled trial of early eptifibatide for non-ST-segment elevation acute coronary syndromes. Am Heart J. 2003 Dec; 146(6):993-8.
Score: 0.014